Tag: IBD-
People With Inflammatory Bowel Disease Face Barriers to Health Care
Barriers include access to treatment, insurance barriers, and financial issues
Researchers Find Biomarker Tied to Severity of Ulcerative Colitis
HLA-DRB1*01:03 allele linked to severe disease requiring hospitalization, major operation, systemic corticosteroid use
FDA Approves Tremfya for Ulcerative Colitis
Approval is for adults with moderately to severely active disease
RSV Infection With Inflammatory Bowel Disease Ups Risk for Hospitalization
Authors say patients with inflammatory bowel disease may benefit from RSV vaccination
Televisit Outpatient Care Feasible for Inflammatory Bowel Disease
No increase seen in IBD-related hospitalizations versus in-person outpatient care
No Link Seen Between Exposure to Immunosuppressive Therapy, Cancer in IBD Patients
No significant association seen between immunosuppression receipt and incident cancer after adjustment for confounders
Risk for Most Cardiovascular Diseases No Higher With Inflammatory Bowel Disease
CVD risk not increased in postmenopausal women with IBD, although risk for ischemic stroke may be elevated
Study IDs Risk Factors for Extraintestinal Manifestations of IBD
Being female, smoking, previous surgeries for IBD, and genetics all tied to higher risk
Higher Vitamin D Levels Cut Bowel Resection Risk With IBD
Findings persist with ulcerative colitis but not Crohn disease
High-Quality Diet at 1 Year of Age Tied to Lower Risk for IBD
Specific risk reduction seen with higher vegetable and fish intake at 1 year of age
